Thrombolytic Therapy in the Extended Window
Author Information
Author(s): O. M. Al‐Janabi, Seyed Behnam Jazayeri, Michelle A. Toruno, Yamama M. Mahmood, Sherief Ghozy, Shadi Yaghi, Alejandro A. Rabinstein, David F. Kallmes
Primary Institution: Department of Neurology Baptist Health Lexington Kentucky USA
Hypothesis
This study is to elucidate the safety and efficacy of IVT in the extended therapeutic window (ETW) in patients with AIS.
Conclusion
The use of IVT in AIS in ETW is beneficial especially with the use of perfusion imaging for patients' selection.
Supporting Evidence
- IVT showed higher rates of functional recovery at 90 days.
- Rate of mortality at 90 days was not different between groups.
- Rate of sICH was higher among the IVT group.
Takeaway
This study found that giving certain medications to stroke patients even after 4.5 hours can help them recover better, especially if doctors use special imaging to choose the right patients.
Methodology
A systematic review and meta-analysis of randomized controlled trials (RCTs) evaluating the safety and efficacy of intravenous thrombolytics for AIS treatment in the extended window.
Potential Biases
Moderate risk of bias in four studies, and high risk of bias in one study.
Limitations
Some studies had small sample sizes, and imaging criteria for inclusion and definitions of sICH differed across studies.
Participant Demographics
59% male, mean age ranged from 63 to 75 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI 1.1–1.34
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website